The "Global Home Infusion Therapy Market (By Product, Application, Region), Impact of COVID-19, Key Company Profiles, Trends and Recent Developments - Forecast to 2028" report has been added to ResearchAndMarkets.com's offering
DUBLIN--(BUSINESS WIRE)--Oct 27, 2022--
The global home infusion therapy market is predicted to reach US$ 53.2 Billion by 2028. Home infusion therapy is a process of subcutaneous or intravenous administration of biologicals or drugs to a person at home. Home infusion therapy offers various benefits such as cost-effective, convenient, offer better outcomes, and have higher safety standards. Various government programs are being implemented to shift patients towards home care and reduce the overall hospitalization and treatment costs.
Additionally, the rise in preference for homecare among patients, particularly for infusion treatment, and the growing developments in infusion devices designed for home usage are some of the key factors anticipated to fuel the market growth.
Moreover, the growing geriatric population and increasing prevalence of cancer, Crohn's disease, multiple sclerosis, nutritional and immune deficiencies, dehydration, and nausea & vomiting are major factors driving the market growth. Many home infusion service providers, such as Option Care Health Inc., are working in collaboration with hospitals to facilitate the shift of patients at home care settings to receive treatment, thus driving market growth.
Global Home Infusion Therapy Market - Recent Developments
In April 2022, CarepathRx, a US-based pharmacy, and medication management solutions, partnered with Mount Sinai Health System, a US-based hospital network. This partnership allows expanding patient access to home infusion therapies across the Mount Sinai Health System, encompassing its eight hospitals and ambulatory footprint.
In May 2021, Smiths Medical and Ivenix, Inc. announced a partnership to deliver a comprehensive range of infusion management solutions to the U.S. market. The goal of this partnership is to enhance infusion administration and patient safety.
In January 2021, Amedisys collaborated with Option Care Health to deliver COVID-19 infusion therapy to the Vulnerable population.
In March 2020, KabaFusion, a leading provider of specialty acute and chronic home infusion therapies, announced that it has acquired the home infusion assets of Lincare, a subsidiary of Linde plc.
By Product - Global Home Infusion Therapy Market and Forecast
Infusion Pump
Intravenous Sets
IV Cannulas
Needleless Connectors
By Application - Global Home Infusion Therapy Market and Forecast
Anti-infective
Enteral Nutrition
Parenteral Nutrition
Specialty Pharmaceuticals
Chemotherapy
Hydration Therapy
Others
By Region - Global Home Infusion Therapy Market and Forecast
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Global Home Infusion Therapy Market - Key Company Profiles
3. Becton, Dickinson and Company
4. Baxter International Inc.
5. Smiths Medical (Now Part of ICU Medical)
10. BriovaRx / OptumRx/ Diplomat (UnitedHealth Group)
21. FlexCare Infusion Centers
2. Impact of COVID-19 on Home Infusion Therapy Market
3. Global - Home Infusion Therapy Market and Forecast (2015 - 2028)
4. Global - Home Infusion Therapy Market Share and Forecast (2015 - 2028)
5. By Product - Global Home Infusion Therapy Market and Forecast (2015 - 2028)
6. By Application - Global Home Infusion Therapy Market and Forecast (2015 - 2028)
7. By Region - Global Home Infusion Therapy Market and Forecast (2015 - 2028)
8. Global Home Infusion Therapy Market - Recent Developments
9. Global Home Infusion Therapy Market - Driving Factors
10. Global Home Infusion Therapy Market - Challenges
11. Global Home Infusion Therapy Market - Key Company Profiles
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: MANAGED CARE PHARMACEUTICAL HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 10/27/2022 07:48 AM/DISC: 10/27/2022 07:48 AM
http://www.businesswire.com/news/home/20221027005611/en